Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Carotid artery web and ischemic stroke: A case-control study.

Coutinho JM, Derkatch S, Potvin AR, Tomlinson G, Casaubon LK, Silver FL, Mandell DM.

Neurology. 2017 Jan 3;88(1):65-69. doi: 10.1212/WNL.0000000000003464. Epub 2016 Nov 18. Erratum in: Neurology. 2017 Aug 1;89(5):521.

2.

Nonstenotic carotid plaque on CT angiography in patients with cryptogenic stroke.

Coutinho JM, Derkatch S, Potvin AR, Tomlinson G, Kiehl TR, Silver FL, Mandell DM.

Neurology. 2016 Aug 16;87(7):665-72. doi: 10.1212/WNL.0000000000002978. Epub 2016 Jul 13.

3.

Report of an IEEE task force--an IEEE opinion on research needs for biomedical engineering systems.

Potvin AR, Crosier WG, Fromm E, Lin JC, Neuman MR, Pilkington TC, Robinson CJ, Schneider LW, Strohbehn JW, Szolovits P, et al.

IEEE Trans Biomed Eng. 1986 Jan;33(1):48-59. No abstract available.

PMID:
3940989
4.

The basis of intra-blood-brain-barrier IgG synthesis.

Tourtellotte WW, Staugaitis SM, Walsh MJ, Shapshak P, Baumhefner RW, Potvin AR, Syndulko K.

Ann Neurol. 1985 Jan;17(1):21-7.

PMID:
3985581
5.

A computer-based system for automated quantitation of neurologic function.

Kondraske GV, Potvin AR, Tourtellotte WW, Syndulko K.

IEEE Trans Biomed Eng. 1984 May;31(5):401-14. No abstract available.

PMID:
6745977
6.

Multimodality evoked potentials and neurophysiological tests in multiple sclerosis. Effects of hyperthermia on test results.

Phillips KR, Potvin AR, Syndulko K, Cohen SN, Tourtellotte WW, Potvin JH.

Arch Neurol. 1983 Mar;40(3):159-64.

PMID:
6830456
7.

Multiple sclerosis-specific central nervous system antigens (MSG2): a blind study.

Rastogi SC, Clausen J, Tourtellotte WW, Potvin AR.

Eur Neurol. 1983;22(1):17-21.

PMID:
6840137
8.

Intra-blood-brain barrier measles virus antibody synthesis in multiple sclerosis patients.

Albrecht P, Tourtellotte WW, Hicks JT, Sato H, Boone EJ, Potvin AR.

Neurology. 1983 Jan;33(1):45-50.

PMID:
6681559
9.

Cognition in Parkinson disease: an event-related potential perspective.

Hansch EC, Syndulko K, Cohen SN, Goldberg ZI, Potvin AR, Tourtellotte WW.

Ann Neurol. 1982 Jun;11(6):599-607.

PMID:
7114809
10.

Isotachophoresis quantitation of subfractions of multiple sclerosis intra-blood-brain barrier IgG synthesis modulated by ACTH and/or steroids.

Tourtellotte WW, Potvin AR, Ma BI, Baumhefner RW, Walsh MJ, Dickstein P, Ingram T, Cowan T, Shapshak P, Delmotte P.

Neurology. 1982 Mar;32(3):261-6. No abstract available.

PMID:
6278361
11.

Parkinson's disease: Cogentin with Sinemet, a better response.

Tourtellotte WW, Potvin AR, Syndulko K, Hirsch SB, Gilden ER, Potvin JH, Hansch EC.

Prog Neuropsychopharmacol Biol Psychiatry. 1982;6(1):51-5.

PMID:
7202230
12.

Endogenous event-related potentials: prospective applications in neuropsychology and behavioral neurology.

Syndulko K, Cohen SN, Tourtellotte WW, Potvin AR.

Bull Los Angeles Neurol Soc. 1982;47:124-40.

PMID:
7183362
13.

Variability on serial testing of visual evoked potentials in patients with multiple sclerosis.

Cohen SN, Syndulko K, Hansch E, Tourtellotte WW, Potvin AR.

Adv Neurol. 1982;32:559-65. No abstract available.

PMID:
7054985
14.

Improved diagnostic yield in evaluation of multiple sclerosis using critical frequency of photic driving with pattern reversal-evoked potentials.

Cohen SN, Syndulko K, Hansch EC, Gilden E, Phillips K, Tourtellotte WW, Potvin AR.

Adv Neurol. 1982;32:459-62. No abstract available.

PMID:
7054970
15.

Long-latency event-related potentials in normal aging and dementia.

Syndulko K, Hansch EC, Cohen SN, Pearce JW, Goldberg Z, Montan B, Tourtellotte WW, Potvin AR.

Adv Neurol. 1982;32:279-85. No abstract available.

PMID:
7054950
16.

Quantification of de novo central nervous system IgG measles antibody synthesis in SSPE.

Tourtellotte WW, Ma BI, Brandes DB, Walsh MJ, Potvin AR.

Ann Neurol. 1981 Jun;9(6):551-6.

PMID:
7259117
17.

Multiple sclerosis serum and cerebrospinal fluid immunoglobulin binding to Fc receptors of oligodendrocytes.

Ma BI, Joseph BS, Walsh MJ, Potvin AR, Tourtellotte WW.

Ann Neurol. 1981 Apr;9(4):371-7.

PMID:
6452854
18.

Decreased verbal memory associated with anticholinergic treatment in Parkinson's disease patients.

Syndulko K, Gilden ER, Hansch EC, Potvin AR, Tourtellotte WW, Potvin JH.

Int J Neurosci. 1981;14(1-2):61-6.

PMID:
7263143
19.

Biomedical engineering education: enrollment, courses, degrees, and employment.

Potvin AR, Long FM, Webster JG, Jendrucko RJ.

IEEE Trans Biomed Eng. 1981 Jan;28(1):22-8. No abstract available.

PMID:
7228064
20.

Quantitative methods in assessment of neurologic function.

Potvin AR, Tourtellotte WW, Syndulko K, Potvin J.

Crit Rev Bioeng. 1981;6(3):177-224. Review.

PMID:
7023834
21.

Increased ratio of carbidopa to levodopa in treatment of Parkinson's disease.

Tourtellotte WW, Syndulko K, Potvin AR, Hirsch SB, Potvin JH.

Arch Neurol. 1980 Nov;37(11):723-6.

PMID:
7436817
22.

Speech sounds: evaluation of a device for their visual presentation.

Potvin AR, Foreit KG, Lam K, Trued S, Potvin JH.

Arch Phys Med Rehabil. 1980 Nov;61(11):542-6.

PMID:
7436717
23.

Multiple sclerosis de novo CNS IgG synthesis: effect of ACTH and corticosteroids.

Tourtellotte WW, Baumhefner RW, Potvin AR, Ma BI, Potvin JH, Mendez M, Syndulko K.

Neurology. 1980 Nov;30(11):1155-62.

PMID:
6252511
24.

Failure of intravenous and intrathecal cytarabine to modify central nervous system IgG synthesis in multiple sclerosis.

Tourtellotte WW, Potvin AR, Mendez M, Baumhefner RW, Potvin JH, Ma BI, Syndulko K.

Ann Neurol. 1980 Oct;8(4):402-8.

PMID:
6893646
25.

Multiple sclerosis de novo CNS IgG synthesis. Effect of CNS irradiation.

Tourtellotte WW, Potvin AR, Baumhefner RW, Potvin JH, Ma BI, Syndulko K, Petrovich Z.

Arch Neurol. 1980 Oct;37(10):620-4.

PMID:
6252876
26.

Skill requirements for the rehabilitation engineer: results of a survey.

Potvin AR, Mercadante TC, Cook AM.

IEEE Trans Biomed Eng. 1980 May;27(5):283-8. No abstract available.

PMID:
7380448
27.

Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate.

Tourtellotte WW, Potvin AR, Fleming JO, Murthy KN, Levy J, Syndulko K, Potvin JH.

Neurology. 1980 Mar;30(3):240-4.

PMID:
7189023
28.

Critical frequency of photic driving in the diagnosis of multiple sclerosis. A comparison to pattern evoked responses.

Cohen SN, Syndulko K, Tourtellotte WW, Potvin AR.

Arch Neurol. 1980 Feb;37(2):80-3.

PMID:
7356412
29.

Human neurologic function and the aging process.

Potvin AR, Syndulko K, Tourtellotte WW, Lemmon JA, Potvin JH.

J Am Geriatr Soc. 1980 Jan;28(1):1-9.

PMID:
7350209
30.

Methodology for analyzing clinical neurological data: ACTH in multiple sclerosis.

Henderson WG, Tourtellotte WW, Potvin AR, Rose AS.

Clin Pharmacol Ther. 1978 Aug;24(2):146-53.

PMID:
209928
31.

Motion sickness and otolith sensitivity: a pilot study of habituation to linear acceleration.

Potvin AR, Sadoff M, Billingham J.

Aviat Space Environ Med. 1977 Nov;48(11):1068-75.

PMID:
921674
32.

Portable clinical tracking-task instrument.

Potvin AR, Doerr JA, Estes JT, Tourtellotte WW.

Med Biol Eng Comput. 1977 Jul;15(4):391-7. No abstract available.

PMID:
197331
33.

A battery of tests for evaluating steadiness in clinical trials.

Potvin AR, Albers JW, Stribley RF, Tourtellotte WW, Pew RW.

Med Biol Eng. 1975 Nov;13(6):914-22. No abstract available.

PMID:
1195885
34.

Quantitative examination of neurological function: reliability and learning effects.

Potvin AR, Tourtellotte WW, Henderson WG, Snyder DN.

Arch Phys Med Rehabil. 1975 Oct;56(10):439-42.

PMID:
1190997
35.

The neurological examination: advancements in its quantification.

Potvin AR, Tourtellotte WW.

Arch Phys Med Rehabil. 1975 Oct;56(10):425-37.

PMID:
1190996
36.

Validity of quantitative tests measuring tremor.

Potvin AR, Tourtellotte WW, Snyder DN, Henderson WG, Albers JW.

Am J Phys Med. 1975 Oct;54(5):243-52.

PMID:
1180353
37.

Training examiners to administer a quantitative neurological examination for a multicenter clinical trial.

Henderson WG, Tourtellotte WW, Potvin AR.

Arch Phys Med Rehabil. 1975 Jul;56(7):289-95.

PMID:
167673
38.

Effects of secobarbital on performance upon arousal from stage 4 sleep.

Potvin AR, Salamy JG, Crosier WG, Jones KW, Doerr JA.

Appl Neurophysiol. 1975;38(4):240-50. No abstract available.

PMID:
1235771
39.

Quantitative evaluation of neuropharmacological trials.

Potvin AR, Albers JW, Repa BS, Henderson WG, Walker JE, Stribley RF, Tourtellotte WW.

Clin Pharmacol Ther. 1974 Mar;15(3):229-38. Review. No abstract available.

40.

The importance of age effects on performance in the assessment of clinical trials.

Potvin AR, Tourtellotte WW, Pew RW, Albers JW, Henderson WG, Snyder DN.

J Chronic Dis. 1973 Nov;26(11):699-717. No abstract available.

41.

Motivation and learning in the quantitative examination of neurological function.

Potvin AR, Tourtellotte WW, Pew RW, Albers JW, Henderson WG, Snyder DN.

Arch Phys Med Rehabil. 1973 Sep;54(9):432-40. No abstract available.

PMID:
4729790
42.

Quantification of hand tremor in the clinical neurological examination.

Albers JW, Potvin AR, Tourtellotte WW, Pew RW, Stribley RF.

IEEE Trans Biomed Eng. 1973 Jan;20(1):27-37. No abstract available.

PMID:
4681807
43.

Simulated activities of daily living examination.

Potvin AR, Tourtellotte WW, Dailey JS, Alberts JW, Walker JE, Pew RW, Henderson WG, Snyder DN.

Arch Phys Med Rehabil. 1972 Oct;53(10):476-86 passim. No abstract available.

PMID:
5079861
44.

A qualitative and quantitative evaluation of amantadine in the treatment of Parkinson's disease.

Walker JE, Albers JW, Tourtellotte WW, Henderson WG, Potvin AR, Smith A.

J Chronic Dis. 1972 Mar;25(3):149-82. No abstract available.

45.

Effects of d-amphetamine on quantitative measures of motor performance.

Domino EF, Albers JW, Potvin AR, Repa BS, Tourtellotte WW.

Clin Pharmacol Ther. 1972 Mar-Apr;13(2):251-7. No abstract available.

46.

[On cancer mortality and morbidity in the Province of Quebec].

Potvin AR.

Union Med Can. 1965 Apr;94(4):442-8. French. No abstract available.

PMID:
5827736
47.

The Quebec Tumour Registry.

Potvin AR.

Can Med Assoc J. 1962 Dec 1;87(22):1206-7. No abstract available.

48.

[Poisonous sting of various fish: Ictalurus nebulosus, Ictalurus punctatus. Research on the envenomization of wounds].

POTVIN AR.

Laval Med. 1961 Jun;32:52-9 contd. French. No abstract available.

PMID:
13737534
49.

[Poisonous sting of various fish: Ictalurus nebulosus, Ictalurus catus. Research on the envenomization of wounds].

POTVIN AR.

Laval Med. 1959 Nov;28:492-503. French. No abstract available.

PMID:
14434494
50.

Le Departement d'Histologie.

POTVIN AR.

Laval Med. 1957 Sep;23(1):173-9. French. No abstract available.

PMID:
13482317

Supplemental Content

Loading ...
Support Center